Measles (MR) Vaccine
The MR (Measles-Rubella) vaccine is a critical component of the national immunization program aimed at eliminating measles and congenital rubella syndrome.
1. Vaccine Profile
| Parameter | Details |
|---|---|
| Type | Live attenuated vaccine. |
| Route/Site | Subcutaneous (Right upper arm). |
| Dosage | 0.5 ml. |
2. Schedule & Indications
- Primary Schedule: Two doses are typically administered at 9-12 months and 16-24 months.
- Contraindications: Pregnancy, severe immunodeficiency (e.g., untreated HIV/AIDS), and anaphylactic reaction to a previous dose or gelatin/neomycin.
- Special Context: In the event of a measles outbreak, the vaccine can be given to children as young as 6 months.
NEET PG Hint: Remember that egg allergy is NOT a contraindication for the measles vaccine because it is grown in chick embryo fibroblasts, which contain negligible amounts of egg protein. Always note that if a child has received Immunoglobulin, vaccination must be delayed for at least 3-6 months.